Partners & Licensees

Partnerships and licensing are a key part of REGENXBIO’s commitment to enabling the ongoing development of gene therapy treatments using our NAV Technology Platform. Our NAV Technology Platform is being applied in the development of over 20 partnered product candidates for a variety of diseases by our NAV Technology Licensees.

Please contact us to discuss partnering or licensing opportunities.